Literature DB >> 6379276

Primary aldosteronism due to adrenal carcinomas.

T Lüscher, W Tenschert, A Salvetti, R Pedrinelli, R Maurer, F Turini, G Maltinti, H Vetter, W Vetter.   

Abstract

In the present study two patients with aldosterone-producing adrenal carcinomas are reported. The clinical features were characterized by hypertension and severe hypokalemia with muscular weakness, flaccid paralysis of arms and legs, diarrhea and polyuria. In both cases excessively high plasma aldosterone levels and suppressed plasma renin activity were found. In contrast to most other cases with aldosterone-secreting tumours plasma cortisol, urinary free cortisol excretion, 17-hydroxy- and 17-ketosteroids were in the normal range. There was no clinical evidence of oversecretion of sex hormones. After adrenalectomy blood pressure and serum potassium normalized and the clinical symptoms disappeared. Plasma aldosterone and urinary aldosterone secretion returned to normal, while plasma renin activity remained low. Three and a half and 6 months later primary aldosteronism and the associated clinical symptoms reappeared due to hormonally active metastases. After introducing the antitumour drug o,p'-DDD in patient 1 aldosterone secretion normalized and the clinical status of the patient markedly improved. However, 10 months after diagnosis the patient died due to a haemorrhage from a liver metastasis. In patient 2 tumour-invaded regional lymph nodes were surgically removed with only minor changes in the hormone pattern.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6379276     DOI: 10.1007/bf01726909

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  47 in total

1.  Adrenocortical carcinoma with gynecomastia: a case report and review of the literature.

Authors:  S WALLACH; H BROWN; E ENGLERT; K EIK-NES
Journal:  J Clin Endocrinol Metab       Date:  1957-08       Impact factor: 5.958

2.  Potassium deficiency of renal and adrenal origin.

Authors:  R V BROOKS; R R McSWINEY; F T PRUNTY; F J WOOD
Journal:  Am J Med       Date:  1957-09       Impact factor: 4.965

3.  Mortality in surgically treated adrenocortical tumors. II. Review of cases reported for the 20 year period 1930-1949, inclusive.

Authors:  E RAPAPORT; M B GOLDBERG; G S GORDAN; F HINMAN
Journal:  Postgrad Med       Date:  1952-04       Impact factor: 3.840

4.  Plasma deoxycorticosterone in man.

Authors:  R D Brown; C A Strott
Journal:  J Clin Endocrinol Metab       Date:  1971-06       Impact factor: 5.958

5.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

6.  Radioimmunoassay for aldosterone without chromatography.

Authors:  W Vetter; H Vetter; W Siegenthaler
Journal:  Acta Endocrinol (Copenh)       Date:  1973-11

7.  Hypermineralocorticoidism: the sole clinical manifestation of an adrenal cortical carcinoma.

Authors:  R Six; R Leclercq; F Noeninckx
Journal:  Acta Clin Belg       Date:  1972       Impact factor: 1.264

8.  Carcinoma of the adrenal cortex with hyperaldosteronism.

Authors:  S Filipecki; T Feltynowski; W Poplawska; K Lapinska; S Krus; B Wocial; W Januszewicz
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

9.  Influence of age and sodium intake on plasma renin activity of normal subjects.

Authors:  A Salvetti; R Pedrinelli; A Magagna; L Poli; P Sassano; F Arzilli
Journal:  Nephron       Date:  1980       Impact factor: 2.847

10.  Hyperaldosteronism caused by adrenal cortical carcinoma.

Authors:  M Revach; S Shilo; S Cabili; Z Rubenstein; G Selzer
Journal:  Isr J Med Sci       Date:  1977-11
View more
  3 in total

Review 1.  Management of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinoma.

Authors:  Irina Veytsman; Lynnette Nieman; Tito Fojo
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

2.  Primary aldosteronism: difference in clinical presentation and long-term follow-up between adenoma and bilateral hyperplasia of the adrenal glands.

Authors:  T Jeck; B Weisser; T Mengden; L Erdmenger; S Grüne; W Vetter
Journal:  Clin Investig       Date:  1994-12

3.  Diagnosis and treatment of cortical tumours of the suprarenal gland.

Authors:  V Zvara; J Breza; M Májek
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.